Your browser doesn't support javascript.
loading
Second-line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real-world eligibility for cabozantinib, regorafenib, and ramucirumab.
Fung, Andrea S; Tam, Vincent C; Meyers, Daniel E; Sim, Hao-Wen; Knox, Jennifer J; Zaborska, Valeriya; Davies, Janine; Ko, Yoo-Joung; Batuyong, Eugene; Samawi, Haider; Cheung, Winson Y; Lee-Ying, Richard.
Affiliation
  • Fung AS; Tom Baker Cancer Centre, Calgary, AB, Canada.
  • Tam VC; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Meyers DE; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Sim HW; Tom Baker Cancer Centre, Calgary, AB, Canada.
  • Knox JJ; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Zaborska V; Tom Baker Cancer Centre, Calgary, AB, Canada.
  • Davies J; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Ko YJ; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia.
  • Batuyong E; Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Samawi H; BC Cancer Agency, Vancouver Centre, Vancouver, BC, Canada.
  • Cheung WY; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Lee-Ying R; BC Cancer Agency, Vancouver Centre, Vancouver, BC, Canada.
Cancer Med ; 9(13): 4640-4647, 2020 07.
Article in En | MEDLINE | ID: mdl-32378799

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Pyridines / Carcinoma, Hepatocellular / Antibodies, Monoclonal, Humanized / Sorafenib / Anilides / Liver Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Cancer Med Year: 2020 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Pyridines / Carcinoma, Hepatocellular / Antibodies, Monoclonal, Humanized / Sorafenib / Anilides / Liver Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Cancer Med Year: 2020 Document type: Article Affiliation country: